Capital World Investors
TEVA icon

Capital World Investors’s Teva Pharmaceuticals TEVA Stock Holding History

Capital World Investors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$266M Buy
8,833,566
+6,472,554
+274% +$208M 0.04% 271
2025
Q4 		$73.7M Buy
+2,361,012
New +$58.2M 0.01% 382
2023
Q3 		– Sell
-119,417
Closed -$904K – 526
2023
Q2 		$904K Sell
119,417
-50,519,746
-100% -$410M ﹤0.01% 495
2023
Q1 		$448M Buy
50,639,163
+75,176
+0.1% +$743K 0.09% 197
2022
Q4 		$461M Buy
50,563,987
+11,234,222
+29% +$98M 0.1% 186
2022
Q3 		$317M Buy
+39,329,765
New +$348M 0.07% 220
2021
Q4 		– Sell
-6,185,616
Closed -$60.2M – 631
2021
Q3 		$60.2M Sell
6,185,616
-43,150,734
-87% -$404M 0.01% 423
2021
Q2 		$488M Sell
49,336,350
-3,684,423
-7% -$39M 0.08% 214
2021
Q1 		$612M Buy
53,020,773
+141,396
+0.3% +$1.62M 0.11% 178
2020
Q4 		$510M Buy
52,879,377
+72,877
+0.1% +$698K 0.1% 196
2020
Q3 		$476M Buy
52,806,500
+9,375,273
+22% +$99.2M 0.1% 190
2020
Q2 		$536M Buy
43,431,227
+10,344,401
+31% +$117M 0.13% 154
2020
Q1 		$297M Sell
33,086,826
-2,626,236
-7% -$26.9M 0.09% 193
2019
Q4 		$350M Buy
35,713,062
+2,065,840
+6% +$18.4M 0.08% 209
2019
Q3 		$231M Sell
33,647,222
-5,958,254
-15% -$45.7M 0.06% 234
2019
Q2 		$366M Sell
39,605,476
-7,023,189
-15% -$84.7M 0.09% 192
2019
Q1 		$731M Sell
46,628,665
-1,509,570
-3% -$26.6M 0.18% 126
2018
Q4 		$742M Buy
48,138,235
+681,516
+1% +$14M 0.2% 121
2018
Q3 		$1.02B Buy
47,456,719
+4,841,681
+11% +$112M 0.25% 111
2018
Q2 		$1.04B Buy
42,615,038
+4,114,223
+11% +$83.9M 0.22% 113
2018
Q1 		$658M Buy
38,500,815
+33,901,815
+737% +$662M 0.15% 148
2017
Q4 		$87.2M Buy
4,599,000
+4,000
+0.1% +$60.2K 0.02% 305
2017
Q3 		$80.9M Sell
4,595,000
-6,473,200
-58% -$146M 0.02% 318
2017
Q2 		$368M Buy
11,068,200
+3,268,200
+42% +$101M 0.09% 178
2017
Q1 		$250M Buy
+7,800,000
New +$266M 0.06% 207
2015
Q2 		– Sell
-200,000
Closed -$12.5M – 544
2015
Q1 		$12.5M Hold
200,000
– – ﹤0.01% 476
2014
Q4 		$11.5M Hold
200,000
– – ﹤0.01% 481
2014
Q3 		$10.8M Hold
200,000
– – ﹤0.01% 475
2014
Q2 		$10.5M Hold
200,000
– – ﹤0.01% 474
2014
Q1 		$10.6M Sell
200,000
-3,230,000
-94% -$149M ﹤0.01% 468
2013
Q4 		$137M Hold
3,430,000
– – 0.04% 264
2013
Q3 		$130M Hold
3,430,000
– – 0.04% 273
2013
Q2 		$134M Buy
+3,430,000
New +$134M 0.04% 268

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors's TEVA Position: Q1 2026 in Review

Capital World Investors increased its Teva Pharmaceuticals (TEVA) stake by 274% in Q1 2026, buying an estimated $208M and bringing the position to 8,833,566 shares worth $266M. The position accounts for 0.04% of the portfolio, ranked #271.

Capital World Investors first reported a position in TEVA in Q2 2013 and has held it in 33 quarters since. The position peaked at $1.04B in Q2 2018. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Capital World Investors held 8,833,566 shares of Teva Pharmaceuticals worth $266M as of Q1 2026.
  • Capital World Investors bought 6,472,554 Teva Pharmaceuticals shares in Q1 2026, an estimated $208M.
  • Teva Pharmaceuticals made up 0.04% of Capital World Investors's portfolio in Q1 2026, its #271 holding.
  • Capital World Investors first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 33 quarters since.
  • Capital World Investors's Teva Pharmaceuticals position peaked at $1.04B in Q2 2018.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Capital World Investors's 13F filing for Q1 2026, filed 13 May 2026.